Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$1.50 USD
-0.01 (-0.66%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.49 -0.01 (-0.67%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | NA |
---|---|
Current Quarter | 0.00 |
EPS Last Quarter | -0.02 |
Last EPS Surprise | 33.33% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.11 |
Next Year | -0.12 |
EPS (TTM) | -0.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 0.33M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 0.33M | NA |
Low Estimate | NA | NA | 0.33M | NA |
Year ago Sales | 2.09M | 2.19M | 1.43M | 0.33M |
Year over Year Growth Est. | NA | NA | -76.99% | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.00 | -0.02 | -0.11 | -0.12 |
# of Estimates | 2 | 2 | 4 | 3 |
Most Recent Consensus | NA | NA | -0.09 | -0.11 |
High Estimate | 0.02 | -0.02 | -0.09 | -0.10 |
Low Estimate | -0.02 | -0.02 | -0.12 | -0.14 |
Year ago EPS | -0.04 | -0.04 | -0.14 | -0.11 |
Year over Year Growth Est. | 100.00% | 50.00% | 21.43% | -10.61% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.00 | -0.02 | -0.11 | -0.12 |
7 Days Ago | 0.00 | -0.02 | -0.11 | -0.12 |
30 Days Ago | -0.03 | -0.03 | -0.09 | -0.13 |
60 Days Ago | -0.03 | -0.03 | -0.13 | -0.13 |
90 Days Ago | -0.03 | -0.03 | -0.12 | -0.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.02 | -0.02 | -0.11 | -0.12 |
Zacks Consensus Estimate | 0.00 | -0.02 | -0.11 | -0.12 |
Earnings ESP | 0.00% | 0.00% | -1.59% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.02 | NA | -0.04 | -0.04 | NA |
Estimate | -0.03 | NA | -0.04 | -0.03 | NA |
Difference | 0.01 | NA | 0.00 | -0.01 | 0.00 |
Surprise | 33.33% | NA | 0.00% | -33.33% | 0.00% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more